These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 8464986

  • 21. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP, Annuk H, Prendergast MM.
    J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
    [Abstract] [Full Text] [Related]

  • 22. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K, Koga M, Takahashi M, Hirata K, Yuki N.
    J Neurol Sci; 2006 Jul 15; 246(1-2):163-8. PubMed ID: 16600306
    [Abstract] [Full Text] [Related]

  • 23. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U, Karch H, Toyka KV, Michels M, Zielasek J, Pette M, Heesemann J, Hartung HP.
    Ann Neurol; 1993 Aug 15; 34(2):136-44. PubMed ID: 8338338
    [Abstract] [Full Text] [Related]

  • 24. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M, Takahashi M, Masuda M, Hirata K, Yuki N.
    Neurology; 2005 Nov 08; 65(9):1376-81. PubMed ID: 16162859
    [Abstract] [Full Text] [Related]

  • 25. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.
    Neurology; 2008 Nov 18; 71(21):1683-90. PubMed ID: 19015484
    [Abstract] [Full Text] [Related]

  • 26. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N.
    Ann Neurol; 2000 Oct 18; 48(4):624-31. PubMed ID: 11026446
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies.
    Lardone RD, Alaniz ME, Irazoqui FJ, Nores GA.
    J Neuroimmunol; 2006 Apr 18; 173(1-2):174-9. PubMed ID: 16376437
    [Abstract] [Full Text] [Related]

  • 31. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA, Chen ZW, Cook SD, Mithen FA, Singhal BS.
    Res Commun Mol Pathol Pharmacol; 2001 Jul 18; 109(1-2):115-23. PubMed ID: 11458979
    [Abstract] [Full Text] [Related]

  • 32. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM, Cai FC, Zhang XP.
    Muscle Nerve; 2006 Feb 18; 33(2):225-31. PubMed ID: 16270308
    [Abstract] [Full Text] [Related]

  • 33. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
    Gregson NA, Rees JH, Hughes RA.
    J Neuroimmunol; 1997 Mar 18; 73(1-2):28-36. PubMed ID: 9058756
    [Abstract] [Full Text] [Related]

  • 34. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ, Pestronk A, Bieser K, Ho TW, McKhann GM, Wu HS, Jiang Z.
    Ann Neurol; 1994 Feb 18; 35(2):234-7. PubMed ID: 8109905
    [Abstract] [Full Text] [Related]

  • 35. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
    Hao Q, Saida T, Yoshino H, Kuroki S, Nukina M, Saida K.
    Ann Neurol; 1999 Jun 18; 45(6):758-68. PubMed ID: 10360768
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
    van den Berg LH, Marrink J, de Jager AE, de Jong HJ, van Imhoff GW, Latov N, Sadiq SA.
    J Neurol Neurosurg Psychiatry; 1992 Jan 18; 55(1):8-11. PubMed ID: 1548508
    [Abstract] [Full Text] [Related]

  • 38. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides.
    Wirguin I, Suturkova-Milosevic L, Della-Latta P, Fisher T, Brown RH, Latov N.
    Ann Neurol; 1994 Jun 18; 35(6):698-703. PubMed ID: 8210226
    [Abstract] [Full Text] [Related]

  • 39. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K, Kamakura K, Ogawa G, Ueda M, Motoyoshi K, Arita M, Kusunoki S.
    Neurology; 2008 Jul 15; 71(3):196-201. PubMed ID: 18625966
    [Abstract] [Full Text] [Related]

  • 40. Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome.
    Prendergast MM, Willison HJ, Moran AP.
    Infect Immun; 1999 Jul 15; 67(7):3698-701. PubMed ID: 10377164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.